Total Payments
$6,394
2024 Payments
$24.68
Companies
31
Transactions
284
Medicare Patients
7,369
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$5,271 (82.4%)
Consulting$862.00 (13.5%)
Other$200.00 (3.1%)
Education$47.93 (0.7%)
Gifts$13.24 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,271 | 273 | 82.4% |
| Consulting Fee | $862.00 | 1 | 13.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 3.1% |
| Education | $47.93 | 5 | 0.7% |
| Gift | $13.24 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $869.93 | 35 | $0 (2022) |
| Baxter Healthcare | $862.00 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $664.45 | 34 | $0 (2022) |
| Fresenius USA Marketing, Inc. | $444.68 | 34 | $0 (2022) |
| Daiichi Sankyo Inc. | $437.80 | 20 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $334.16 | 19 | $0 (2022) |
| OPKO Pharmaceuticals, LLC | $279.72 | 14 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $277.12 | 15 | $0 (2022) |
| Vifor Pharma, Inc. | $275.74 | 6 | $0 (2022) |
| Relypsa, Inc. | $270.25 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.68 | 1 | Travere Therapeutics, Inc. ($24.68) |
| 2023 | $134.22 | 2 | GENZYME CORPORATION ($102.43) |
| 2022 | $1,364 | 67 | Daiichi Sankyo Inc. ($259.03) |
| 2021 | $2,377 | 71 | Baxter Healthcare ($862.00) |
| 2020 | $448.47 | 23 | AstraZeneca Pharmaceuticals LP ($104.76) |
| 2019 | $745.70 | 43 | Amgen Inc. ($146.74) |
| 2018 | $628.12 | 36 | Amgen Inc. ($160.99) |
| 2017 | $671.43 | 41 | Keryx Biopharmaceuticals, Inc. ($125.12) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.68 | General |
| 07/11/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $102.43 | General |
| Category: Genetic Disease | ||||||
| 04/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: KRYSTEXXA | ||||||
| 11/29/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/14/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/20/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/15/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/13/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/30/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Nephrology | ||||||
| 08/25/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/24/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 08/23/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEPHROLOGY | ||||||
| 08/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Cardio-renal | ||||||
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardio-renal | ||||||
| 07/27/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/26/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Nephrology | ||||||
| 07/20/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: LUPUS NEPHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,835 | 4,350 | $1.7M | $648,481 |
| 2022 | 13 | 1,849 | 3,976 | $1.4M | $546,652 |
| 2021 | 13 | 1,763 | 3,510 | $1.2M | $497,255 |
| 2020 | 13 | 1,922 | 3,851 | $1.2M | $451,184 |
Total Patients
7,369
Total Services
15,687
Medicare Billing
$2.1M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 282 | 895 | $537,000 | $253,547 | 47.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 337 | 890 | $267,000 | $83,964 | 31.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 186 | 302 | $166,100 | $71,526 | 43.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 34 | 278 | $166,800 | $65,274 | 39.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 259 | 920 | $184,000 | $57,989 | 31.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 315 | 380 | $151,800 | $50,515 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 294 | $73,500 | $28,976 | 39.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 53 | 94 | $47,000 | $15,044 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 171 | $25,650 | $11,551 | 45.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 43 | $12,900 | $4,312 | 33.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 21 | $12,600 | $3,578 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,550 | $1,829 | 40.2% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 20 | 49 | $1,470 | $375.83 | 25.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 274 | 648 | $388,800 | $185,967 | 47.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 333 | 788 | $236,400 | $66,955 | 28.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 306 | 1,063 | $212,600 | $62,480 | 29.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 143 | 229 | $125,950 | $54,542 | 43.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 28 | 231 | $138,600 | $54,541 | 39.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 294 | 337 | $134,800 | $52,846 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 271 | $67,750 | $27,052 | 39.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 53 | 89 | $44,500 | $14,775 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 198 | $29,700 | $13,151 | 44.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 60 | $18,000 | $6,641 | 36.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 19 | $11,400 | $3,148 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,300 | $2,419 | 38.4% |
About Dr. Parham Mokri, M.D
Dr. Parham Mokri, M.D is a Nephrology healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720036692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parham Mokri, M.D has received a total of $6,394 in payments from pharmaceutical and medical device companies, with $24.68 received in 2024. These payments were reported across 284 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,271).
As a Medicare-enrolled provider, Mokri has provided services to 7,369 Medicare beneficiaries, totaling 15,687 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Bakersfield, CA
- Active Since 05/04/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1720036692
Products in Payments
- Renal - Revaclear (Device) $862.00
- Veltassa (Drug) $545.99
- LOKELMA (Drug) $484.15
- Parsabiv (Drug) $439.96
- INJECTAFER (Drug) $437.80
- Parsabiv (Biological) $429.97
- Velphoro (Drug) $429.13
- Kerendia (Drug) $334.16
- Auryxia (Drug) $327.74
- JYNARQUE (Drug) $237.68
- BENLYSTA (Biological) $232.23
- Rayaldee (Drug) $195.93
- FARXIGA (Drug) $180.30
- KRYSTEXXA (Biological) $177.88
- LUPKYNIS (Drug) $174.09
- FABRAZYME (Biological) $102.43
- RAYALDEE (Drug) $83.79
- Rituxan (Biological) $68.49
- KRYSTEXXA (Drug) $59.71
- ENTRESTO (Drug) $59.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bakersfield
Dr. Harold Baer, M.d. Facp, M.D. FACP
Nephrology — Payments: $5,326
Nephrology $5,326
Dr. William Bichai, M.d, M.D
Nephrology — Payments: $3,117
Nephrology $3,117
Dr. Tariq Mubin, M.d, M.D
Nephrology — Payments: $3,074
Nephrology $3,074
Dr. Harjeet Brar, M.d, M.D
Nephrology — Payments: $1,717
Nephrology $1,717
Dr. Arvind Shah, M.d, M.D
Nephrology — Payments: $465.30
Nephrology $465.30
Caroline Wong, Md, MD
Nephrology — Payments: $300.00
Nephrology $300.00